Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Viemed Healthcare, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $270.28M | $224.26M | $183.01M | $138.83M | $117.06M | $131.31M | $80.26M | $65.27M | $46.93M | $31.36M |
| Revenue Growth? | +20.5% | +22.5% | +31.8% | +18.6% | -10.8% | +63.6% | +23.0% | +39.1% | +49.7% | 0.0% |
| Cost of Revenue? | $114.82M | $91.05M | $70.22M | $54.15M | $43.65M | $51.20M | $24.25M | $16.69M | $12.31M | $12.50M |
| Gross Profit? | $155.46M | $133.20M | $112.78M | $84.68M | $73.41M | $80.11M | $56.01M | $48.58M | $34.62M | $18.86M |
| Gross Margin? | +57.5% | +59.4% | +61.6% | +61.0% | +62.7% | +61.0% | +69.8% | +74.4% | +73.8% | +60.1% |
| Operating Expenses? | $134.75M | $115.30M | $98.45M | $76.43M | $61.83M | $53.33M | $47.15M | $31.54M | $20.65M | $14.10M |
| Operating Income? | $20.71M | $17.90M | $14.33M | $8.25M | $11.58M | $26.78M | $8.86M | $17.05M | $8.82M | $383,000 |
| EBITDA? | $51.56M | $42.31M | $36.68M | $24.82M | $24.13M | $36.45M | $15.51M | $13.89M | $11.37M | $1.81M |
| Income Before Tax | $21.77M | $16.17M | $14.39M | $8.99M | $12.50M | $26.36M | $8.80M | $10.34M | $8.19M | $109,000 |
| Income Tax Expense | $6.39M | $4.76M | $4.15M | $2.77M | $3.38M | -$5.17M | $271,000 | $162,000 | $15,000 | -$1.12M |
| Net Income? | $14.93M | $11.27M | $10.24M | $6.22M | $9.13M | $31.53M | $8.53M | $10.18M | $8.18M | $1.23M |
| EPS? | $0.38 | $0.29 | $0.27 | $0.15 | $0.23 | $0.86 | $0.23 | $0.27 | $0.22 | $0.03 |
| Diluted EPS? | $0.37 | $0.28 | $0.25 | $0.15 | $0.22 | $0.82 | $0.22 | $0.26 | $0.22 | $0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality